UK Markets close in 2 hrs 45 mins

Newron Pharmaceuticals S.p.A. (NWPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
2.10000.0000 (0.00%)
At close: 03:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.65
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32.8000
52-week low 32.1000
50-day moving average 32.1000
200-day moving average 32.2190

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 517.85M
Implied shares outstanding 6N/A
Float 816.96M
% held by insiders 14.96%
% held by institutions 17.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021


Profit margin -258.61%
Operating margin (ttm)-214.46%

Management effectiveness

Return on assets (ttm)-15.19%
Return on equity (ttm)-146.43%

Income statement

Revenue (ttm)5.76M
Revenue per share (ttm)0.32
Quarterly revenue growth (yoy)12.40%
Gross profit (ttm)5.76M
EBITDA -12.31M
Net income avi to common (ttm)-14.9M
Diluted EPS (ttm)-1.2390
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.59M
Total cash per share (mrq)1.94
Total debt (mrq)43.08M
Total debt/equity (mrq)1,386.58
Current ratio (mrq)10.79
Book value per share (mrq)0.49

Cash flow statement

Operating cash flow (ttm)-11.45M
Levered free cash flow (ttm)-10.04M